Welcome to Vista
Bridging Science and Practice to Improve Clinical Care
Dedicated to Advancing Research on Alcohol and Drugs and Improving Behavioral Health Care for Young People
Let's make a difference, together.
〰️
Click here to join a Vista clinical trial.
〰️
Let's make a difference, together. 〰️ Click here to join a Vista clinical trial. 〰️
Our Mission
Our mission is to support innovative research and advance clinical care to confront this mounting drug crisis and discover new ways to help individuals and families improve their health and wellness.
Get news and updates in your inbox.
Sign up with your email to receive news about the latest research findings, our newly funded research projects, and practical guidance for people looking to reduce their substance use, parents, teachers and school administrators, and health care professionals.
Reimagining the Integration of Science and Practice
As clinicians and scientists, we know firsthand the day-to-day challenges we face in the clinical management of alcohol and other drug problems in youth along with the shortcomings of the best available therapies. We are committed to translating the latest scientific discoveries to advance clinical care.
What We Do
We conduct research and offer services to help young people take control of their alcohol and other drug use.
Innovating Through Research
Funded by the National Institutes of Health, our research initiatives leverage innovative technologies and the latest scientific knowledge in behavioral and biomedical sciences to uncover what drives addiction and develop new intervention strategies.
Advancing Clinical Care
In partnership with Bradley Hospital, we are at the forefront of transforming behavioral health care for teens and young adults by applying the latest research discoveries to optimize service delivery and support sustainable treatment outcomes.
Supporting Communities
Engaging and supporting communities, schools, and others who strive to help confront our worsening drug crisis and safeguard young people are essential to our mission.
In the news
-
![]()
Dr. Rosales receives a competitive fellowship award from eIRTI.
April 2022
Dr. Robert Rosales receiving a fellowship award from the Enhanced Interdisciplinary Research Training Institute on Hispanic Substance Abuse (eIRTI) at the University of Southern California.
-
![]()
TIME magazine interviews Dr. Miranda about teen drug use.
March 2022
TIME magazine interviews Dr. Robert Miranda about teen drug use and its depiction in the HBO series, Euphoria.
“What Euphoria Gets Right -and Wrong- About Teen Drug Use and Addiction” Read more.
-
![]()
Dr. Carpenter receives an early-career development award from the NIH.
March 2022
Dr. Ryan Carpenter receives an award from the National Institute on Alcohol Abuse and Alcoholism to advance treatment options for people who struggle with both alcohol and opioid problems.
-
![]()
Dr. Miranda joins The Addiction Psychologist Podcast.
November 2021
Dr. Miranda joins The Addiction Psychologist Podcast, produced by Division 50 of the American Psychological Association, to discuss treating adolescents with substance use disorders including findings from his latest research.
-
![]()
Dr. Mereish presents an invited talk at the NIH.
November 2021
Dr. Ethan Mereish presents an invited talk at the 2021 NIH Behavioral and Social Sciences Research Festival. Data for this presentation are from Drs. Mereish and Miranda's NIH-funded research study on minority stress and nicotine use among sexual minority youth who use nicotine.
-
![]()
Dr. Miranda presents grand rounds for child & adolescent psychiatry.
September 2021
Dr. Robert Miranda presents Child and Adolescent Psychiatry Grand Rounds at the Warren Alpert Medical School of Brown University. The title of his talk is “Adolescent Substance Use and Treatment: Translating Science into Clinical Practice”
-
![]()
Dr. Pielech is selected to co-chair national committee focused on youth.
August 2021
Dr. Melissa Pielech is selected to co-chair the Intervention Committee of the Adolescent and Young Adult Special Interest Group through the Society of Pediatric Psychology, Division 54 of the American Psychological Association.
-
![]()
Dr. Parnes receives an individual fellowship award from the NIH.
August 2021
Dr. Jamie Parnes receives a fellowship award (F32) from the NIH to study treatment effects, mechanisms, and moderators in youth cannabis use treatment. The award funded by the NIH National Institute on Drug Abuse and sponsored by Bradley Hospital and Brown University.
-
![]()
Dr. Pielech receives a career development award from the NIH.
August 2021
Dr. Melissa Pielech receives an NIH award to adapt and integrate evidence-based brief interventions for teen substance use and pain into a novel, pre-surgical brief intervention for teens who are undergoing wisdom tooth extraction and their caregiver(s).
-
![]()
Dr. Rosales receives an early-career development award from the NIH.
June 2021
Dr. Robert Rosales receives an award from the National Institute on Minority Health and Health Disparities to study socio-cultural protective and risk factors of alcohol use among non-Hispanic White and Hispanic sexual minority youth.
-
![]()
Dr. Treloar Padovano receives a national research award.
June 2021
Dr. Hayley Treloar Padovano receives the Early Career Investigator Award from the Research Society on Alcoholism. This award recognizes an early career investigator who has demonstrated research excellence, potential to be a future leader and a commitment to the alcohol field.
-
![]()
Bradley Vista named a model treatment program for adolescents.
February 2021
Just 3 years after its launch, Bradley Vista receives national recognition from the Substance Abuse and Mental Health Services Administration as one of five model programs in the United States for treating youth who struggle with substance use and mental health issues.
Featured Projects
Let’s end addiction. Our featured projects represent our ongoing efforts to continue advancing treatments for individuals who struggle to reduce their alcohol and other drug use.
-
Principal Investigator: Robert Miranda Jr.
This study examines the effects of atomoxetine, an FDA-approved non-stimulant medication for treating ADHD, on alcohol use in youth. Participants take the study medication for 6 weeks and receive a computerized alcohol education program. We are looking for individuals ages 14-19 who are interested in reducing their alcohol use. Youth receive over $500 for their participation.
Support: National Institutes of Health (AA026326)
-
Principal Investigator: Robert Miranda Jr.
This study examines lamotrigine, a medicine already approved by the FDA to treat other conditions in children, teens, and adults, on alcohol use in youth. Participants take the study medication for 9 weeks and receive a computerized alcohol education program. We are looking for individuals ages 16-19 who are interested in reducing their alcohol use. Youth receive over $500 for their participation
Support: National Institutes of Health (AA028394)
-
Principal Investigator: Robert Miranda Jr.
In collaboration with the National Institute on Alcohol Abuse and Alcoholism, this project will test the effects of a new medication on alcohol craving and use in adults. Participants take the study medication for 6 weeks and receive a computerized alcohol education program. We will be looking for individuals ages 21 and older who are interested in reducing their drinking. Individuals can earn up to $595.
Support: National Institutes of Health (75N94021D00004)
